NFKB1 and inflammatory response: They reduce the response of the immune system to pulmonary inflammation by activating protein G receptors on macrophages and neutrophils, inhibiting 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase, histone deacetylase, and NF‐κB (Kau et al. 2011; Meier 2009; Trompette et al. 2014).